Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gajewski

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|September 20, 2005
Sarcoidosis mimicking recurrent endometrial cancerJohn L Powell, Erica S Cunill, Walter H Gajewski, et al.
Rhode Island Medicine|May 1, 1995
'You may think I'm too old, but can't you treat my cancer?'P A DiSilvestro, C O Granai, W H Gajewski, et al.
Gynecologic Oncology|April 1, 1994
Prognostic significance of DNA content in epithelial ovarian cancerW H Gajewski, A F Fuller, C Pastel-Ley, et al.
The Journal of Reproductive Medicine|October 14, 2005
Preoperative serum CA-125 levels in treating endometrial cancerJohn L Powell, Kelly A Hill, Brian C Shiro, et al.
Obstetrics and Gynecology|November 1, 1995
Malignant mixed mesodermal tumors of the ovaryP A DiSilvestro, W H Gajewski, M E Ludwig, et al.
Cancer Research|July 15, 1987
Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assayH J Fingert, Z Chen, N Mizrahi, et al.
Gynecologic Oncology|July 1, 1999
Secretion of activin A in recurrent epithelial ovarian carcinomaG M Lambert-Messerlian, S E DePasquale, W M Maybruck, et al.
Gynecologic Oncology|June 1, 1997
Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancerG M Lambert-Messerlian, M Steinhoff, W Zheng, et al.
Cancer Investigation|January 1, 1991
Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapyL A Leone, P A Meitner, T J Myers, et al.
Gynecologic Oncology|December 31, 1997
S-Phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancerM E Gordinier, M M Steinhoff, J W Hogan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|September 20, 2005
Sarcoidosis mimicking recurrent endometrial cancerJohn L Powell, Erica S Cunill, Walter H Gajewski, et al.
Rhode Island Medicine|May 1, 1995
'You may think I'm too old, but can't you treat my cancer?'P A DiSilvestro, C O Granai, W H Gajewski, et al.
Gynecologic Oncology|April 1, 1994
Prognostic significance of DNA content in epithelial ovarian cancerW H Gajewski, A F Fuller, C Pastel-Ley, et al.
The Journal of Reproductive Medicine|October 14, 2005
Preoperative serum CA-125 levels in treating endometrial cancerJohn L Powell, Kelly A Hill, Brian C Shiro, et al.
Obstetrics and Gynecology|November 1, 1995
Malignant mixed mesodermal tumors of the ovaryP A DiSilvestro, W H Gajewski, M E Ludwig, et al.
Cancer Research|July 15, 1987
Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assayH J Fingert, Z Chen, N Mizrahi, et al.
Gynecologic Oncology|July 1, 1999
Secretion of activin A in recurrent epithelial ovarian carcinomaG M Lambert-Messerlian, S E DePasquale, W M Maybruck, et al.
Gynecologic Oncology|June 1, 1997
Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancerG M Lambert-Messerlian, M Steinhoff, W Zheng, et al.
Cancer Investigation|January 1, 1991
Predictive value of the fluorescent cytoprint assay (FCA): a retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapyL A Leone, P A Meitner, T J Myers, et al.
Gynecologic Oncology|December 31, 1997
S-Phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancerM E Gordinier, M M Steinhoff, J W Hogan, et al.
Pageof 4